Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
259
-
Total 13F shares, excl. options
-
32.2M
-
Shares change
-
+548K
-
Total reported value, excl. options
-
$4.56B
-
Value change
-
+$83.1M
-
Put/Call ratio
-
0.37
-
Number of buys
-
116
-
Number of sells
-
-112
-
Price
-
$141.76
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2021
297 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2021.
CONMED Corp - Common Stock (CNMD) has 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.2M shares
.
Largest 10 shareholders include BlackRock Inc. (4.63M shares), VANGUARD GROUP INC (3.17M shares), EARNEST PARTNERS LLC (1.52M shares), Champlain Investment Partners, LLC (1.49M shares), AMERIPRISE FINANCIAL INC (1.16M shares), Capital Research Global Investors (1.13M shares), STATE STREET CORP (1.02M shares), Invesco Ltd. (951K shares), JPMORGAN CHASE & CO (832K shares), and PRINCIPAL FINANCIAL GROUP INC (777K shares).
This table shows the top 259 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.